Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Errington-Mais

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Biotechnology|July 12, 2011
Recent clinical experience with oncolytic virusesO G Donnelly, F Errington-Mais, R Prestwich, et al.
British Journal of Cancer|December 3, 2011
Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particlesS J Win, D G G McMillan, F Errington-Mais, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|February 8, 2014
Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other virusesR V Dave, A H S Jebar, V A Jennings, et al.
International Journal of Cancer|August 29, 2013
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascitesV A Jennings, E J Ilett, K J Scott, et al.
Gene Therapy|December 16, 2011
Measles virus causes immunogenic cell death in human melanomaO G Donnelly, F Errington-Mais, L Steele, et al.
Leukemia|March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemiaC Parrish, G B Scott, G Migneco, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Biotechnology|July 12, 2011
Recent clinical experience with oncolytic virusesO G Donnelly, F Errington-Mais, R Prestwich, et al.
British Journal of Cancer|December 3, 2011
Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particlesS J Win, D G G McMillan, F Errington-Mais, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|February 8, 2014
Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other virusesR V Dave, A H S Jebar, V A Jennings, et al.
International Journal of Cancer|August 29, 2013
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascitesV A Jennings, E J Ilett, K J Scott, et al.
Gene Therapy|December 16, 2011
Measles virus causes immunogenic cell death in human melanomaO G Donnelly, F Errington-Mais, L Steele, et al.
Leukemia|March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemiaC Parrish, G B Scott, G Migneco, et al.
Pageof 1